Jun 10, 2026 07:01AM
Jun 10, 2026 07:00AM
May 11, 2026 04:05PM
Apr 16, 2026 07:00AM
Mar 18, 2026 07:00AM
Mar 3, 2026 07:02AM
Mar 3, 2026 07:00AM Harrow to Initiate Phase 3 Clinical Trial Seeking to Expand TRIESENCE® Label to Include Ocular Inflammation and Pain Following Cataract Surgery Indication
Mar 2, 2026 04:05PM
Feb 17, 2026 07:00AM
Feb 4, 2026 06:48AM
Feb 2, 2026 07:02AM
Feb 2, 2026 07:00AM
Nov 18, 2025 07:01AM
Nov 18, 2025 07:00AM Harrow Announces Closing of Acquisition of Melt Pharmaceuticals
Nov 10, 2025 04:05PM
Oct 6, 2025 07:00AM
Oct 6, 2025 07:00AM
Sep 26, 2025 07:00AM
Sep 26, 2025 07:00AM
Sep 25, 2025 04:06PM
Sep 25, 2025 04:05PM Harrow Launches Harrow Access for All (HAFA)
Sep 23, 2025 06:45AM
Sep 15, 2025 07:00AM
Aug 11, 2025 04:01PM
Jul 17, 2025 07:00AM
Jul 17, 2025 07:00AM
Jun 18, 2025 07:00AM
Jun 9, 2025 07:03AM Harrow Health (HROW) Acquires U.S. Commercial Rights to BYQLOVI
Jun 9, 2025 07:00AM
May 8, 2025 04:01PM
Apr 10, 2025 07:00AM
Mar 27, 2025 04:01PM
Mar 24, 2025 07:05AM
Mar 24, 2025 07:00AM
Mar 17, 2025 04:01PM Harrow Provides Fourth Quarter and Year-End 2024 Unaudited Preliminary Financial Results and 2025 Revenue Guidance
Mar 17, 2025 07:00AM
Mar 11, 2025 07:00AM
Jan 27, 2025 07:30AM
Jan 7, 2025 07:01AM
Jan 7, 2025 07:00AM
Nov 21, 2024 07:02AM
Nov 21, 2024 07:00AM Harrow’s ImprimisRx Subsidiary Receives $34.9 Million Unanimous Jury Verdict Award in ImprimisRx, LLC v. OSRX, Inc.
Nov 13, 2024 04:34PM
Nov 13, 2024 07:00AM
Nov 12, 2024 07:07AM
Nov 12, 2024 07:00AM
Nov 7, 2024 07:00AM
Oct 3, 2024 07:02AM
Oct 3, 2024 07:00AM Harrow Relaunches TRIESENCE®
Aug 7, 2024 04:01PM

1,160,153 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All